News & Events - Press Release In 2026

Read News By Date

Cleanascite™ Cited in Ovarian Cancer Study to Overcome Immunotherapy Resistance

MONMOUTH JUNCTION, NJ, March 18, 2026 — Biotech Support Group (BSG), a leader in proteomics sample preparation, highlights a recent study utilizing its proprietary lipid removal reagent, Cleanascite™, to investigate mechanisms of immunotherapy resistance in ovarian cancer omental metastases.
Read More

AlbuSorb™ PLUS Enables Systems Biology Discovery in Colchicine Cardiovascular Study

MONMOUTH JUNCTION, NJ, March 16, 2026 — Biotech Support Group (BSG), a pioneer in proteomics sample preparation, reports on the use of AlbuSorb™ PLUS in a groundbreaking study published in the European Journal of Pharmacology.
Read More

HemogloBind™ Advances Proteomic Study of Temperature Induced Changes to Lung and Intestines

MONMOUTH JUNCTION, NJ, February 17, 2026 — A research team from Taipei Medical University, describes HemogloBind™ methods as advantageous in a proteomic comparison of lung and intestinal tissues from mice exposed to high temperature, low temperature, and high-to-low temperature groups.
Read More

Cleanascite™ Cited in Study of Post-mortem Inter-animal Chemical Signaling

MONMOUTH JUNCTION, NJ, February 17, 2026 — Biotech Support Group (BSG) reports on its proprietary lipid removal reagent, Cleanascite™, in a worm model study of signaling pathways that promote death avoidance, and thus, survival of conspecifics.
Read More

HemoVoid™ Advances Multi-omic Study of Thalassemia Severity

MONMOUTH JUNCTION, NJ, February 17, 2026 — An article let by researchers from The University of Burdwan, India utilized HemoVoid™ enrichment in a multi-omic study of thalassemia. The citation is: Mitra, Nibedita, et al. "Multi-omics analysis of red blood cells reveals thalassemia severity beyond globin gene mutations." Blood Advances (2026): bloodadvances-2025016677.
Read More

Cleanascite™ Cited in Stroke Research Study

MONMOUTH JUNCTION, NJ, February 6, 2026 — Biotech Support Group (BSG) reports on its proprietary lipid removal reagent, Cleanascite™, as a essential method to assess the functional effects of circulating lipids after stroke.
Read More

Cleanascite™ Cited in Nature Study of Neuronal Proteostasis with Age

MONMOUTH JUNCTION, NJ, January 29, 2026 — Biotech Support Group (BSG) reports on its proprietary lipid removal reagent, Cleanascite™, in a mouse model study of neuronal protein maintenance and the accumulation of protein aggregates with ageing.
Read More

Research Article cites AlbuVoid™ in Stem Cell Secretome Characterization

MONMOUTH JUNCTION, NJ, January 19, 2026 — Biotech Support Group (BSG) reports on its NRicher™-derived product, AlbuVoid™, for secretome analysis of a human induced pluripotent stem cell (hiPSC) -derived product to promote successful reproductive outcomes.
Read More

HemogloBind™ Advances Proteomic Study of Hemolytic Anemia

MONMOUTH JUNCTION, NJ, January 5, 2026– A research pre-print entitled “Ubiquitination and degradation of CD47 enhances macrophage phagocytosis of hemolytic erythrocytes“, describes HemogloBind™ methods to advantage in a proteomic comparison of erythrocytes.
Read More

News & Events - Press Release In 2026

Company

Support